Officer received an award of 6,100 LH derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Feb 10, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Feb 12, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000920148-26-000060
- Filed / recorded
Feb 12, 2026, 8:32 PM UTCAdded to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerLABCORP HOLDINGS INC. Reporting personBrian J Caveney Officer titleEVP, Pres of ED, CMO & CSO SecurityNon-qualified Stock Options TableDerivative (Table II) Transaction dateFeb 10, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.
- The option vests in three equal annual installments beginning on the date reflected in this column.
Around the same time
Traded Feb 11 · disclosed 27 days laterDependent child
2 different filers disclosed LH within 90 days.
Traded Feb 4 · disclosed 34 days laterDependent child
2 different filers disclosed LH within 90 days.
Traded Mar 3 · filed 2 days laterNot under a reported trading plan
The CEO of Labcorp sold $2.44M of Labcorp shares. The filing does not indicate a pre-arranged trading plan.